A detailed history of Derbend Asset Management transactions in Pfizer Inc stock. As of the latest transaction made, Derbend Asset Management holds 10,232 shares of PFE stock, worth $273,603. This represents 0.14% of its overall portfolio holdings.

Number of Shares
10,232
Previous 10,679 4.19%
Holding current value
$273,603
Previous $307,000 7.82%
% of portfolio
0.14%
Previous 0.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $11,572 - $13,289
-447 Reduced 4.19%
10,232 $283,000
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $4,311 - $5,600
-165 Reduced 1.52%
10,679 $307,000
Q3 2023

Oct 19, 2023

SELL
$32.09 - $37.51 $17,553 - $20,517
-547 Reduced 4.8%
10,844 $359,000
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $48,762 - $56,416
-1,350 Reduced 10.6%
11,391 $417,000
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $34,387 - $44,767
-873 Reduced 6.41%
12,741 $519,000
Q4 2022

Jan 24, 2023

SELL
$41.75 - $54.5 $44,004 - $57,443
-1,054 Reduced 7.19%
13,614 $0
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $1,400 - $1,709
32 Added 0.22%
14,668 $642,000
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $86,080 - $102,064
-1,850 Reduced 11.22%
14,636 $767,000
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $7,933 - $11,760
-192 Reduced 1.15%
16,486 $974,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $28,888 - $37,109
-736 Reduced 4.23%
16,678 $717,000
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $625,336 - $708,401
17,414 New
17,414 $682,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Derbend Asset Management Portfolio

Follow Derbend Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Derbend Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Derbend Asset Management with notifications on news.